Monday 15 September 2014

The Making Of The Roskamp Institute Under The Guidance Of Dr. Michael Mullan

Getting to know about the stories of great personalities is really an asset to one’s knowledge. These are real inspiring stories which let you learn that success never comes to those who always just dream for it; it only comes to those who work in the direction of turning those dreams into reality. 

One such great personality who had fervour to do something extraordinary is Michael Mullan. He is the greatest scientists that the world has ever had. He had the zeal to discover remedies for brain disorders and he dedicated his life into research of these diseases. Even today, he does not believe in taking rest and is still working towards developing better solutions for Alzheimer’s disease.


An Insight View of Michael Mullan’s Academic Career 
Dr. Michael Mullan completed his graduation as a medical practitioner. He started his first research work at the Institute of Psychiatry, London University. Here, he began his research in the field of molecular genetics. After this, he attained a Mental Health Foundation Research Fellowship at St. Mary’s Hospital Medical School to retrain in molecular genetics. 

He was senior author on several articles and research papers pertaining to the genetic disturbances which lead to the early onset of Alzheimer. He has served as a co-author for more than 200 research papers associated with the Alzheimer’s disease. He has also worked as a professor of Pathology, Neurology and Psychiatry. In the year 1992, he joined the University in Tampa and established the Roskamp Laboratories.

Inception of Roskamp Institute
In the year 1998, Michael Mullan established the famous Roskamp Institute. This institute has been set up to find better and effective treatments for the Alzheimer’s disease and other brain disorders. In the year 2003, this institute was relocated to a fully fledged research facility in Sarasota, Florida. He is currently operating as the President of the Roskamp Institute. He is also the CEO of the Archer Pharmaceuticals. This institute consists of more than 70 scientists, students, clinical and support staff pursuing advanced scientific understanding of neuropyschiatric diseases. 

This institute is funded through multifarious sources such as the National Institutes of Health, the Veteran’s Administration, the Alzheimer’s Association and the Department of Defence. This institute has also conducted a clinical trial of Alzheimer in Europe with a new and safe medicinal drug which shows greater and faster recovery in humans. Here, Dr. Mullan also discovered the beta-amyloid proteins and their association with the Alzheimer’s disease.

Contributions of Dr. Mullan towards Neuropsychiatric Disorders
Dr. Mullan is a well known biomedical researcher. Under his expert guidance, the institute of Roskamp is earning accolades from worldwide for its advanced research works in the spheres of Traumatic Brain Research, Gulf War Syndrome, Alzheimer’s disease and other neuropsychiatric disorders. 

Moreover, Dr. Mullan has also discovered certain new factors which are leading to this perilous disease. He has also described some really easy methods to prevent as well as cure this disease when detected at the early stages. His research work has also contributed immensely in identifying the well known Swiss Mutation. 

It can be deduced from above that Michael Mullan Roskamp is a man of firm-determination and finds the purpose of his life in serving the mankind in the best way he can.